Lv1
48 积分 2021-05-10 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
2个月前
已完结
Genetic profiling of cell-free DNA from cerebrospinal fluid: opening the barrier to leptomeningeal metastasis in EGFR-mutant NSCLC
3个月前
已完结
Liquid biopsies across the cancer care continuum
8个月前
已完结
Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases
8个月前
已完结
Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential
8个月前
已完结
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR -Mutated Advanced NSCLC
9个月前
已完结
Phase 2 study of amivantamab plus lazertinib in previously-treated patients with EGFR mutant lung cancers with brain and leptomeningeal metastases
10个月前
已完结
Clinical relevance of extracellular vesicles in cancer — therapeutic and diagnostic potential
10个月前
已完结
Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care
1年前
已完结
Leptomeningeal metastatic disease: new frontiers and future directions
1年前
已完结
皖公网安备34019202002308
